Lapsed Dec 27, 2020 on the fee record · Medium confidence
20-year base term ends Apr 19, 2032
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 9,556,274), so the cap could be lower.
First maintenance fee unpaid; grace period ended.
Apr 19, 2012
Dec 27, 2020
Dec 27, 2016
Apr 19, 2032
Its term would have run to Apr 19, 2032: its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 19, 2012, when application 13/451,135, the earliest non-provisional in its chain, was filed (this one was filed Sep 17, 2015) | Apr 19, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,476,409, US 9,556,274) | resolves to Apr 19, 2032, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | lapsed Dec 27, 2020 | High confidence |
| Computed term end | The steps above, in order | Dec 27, 2020 | Medium confidence |
This family
| US 8,476,409 | In force Apr 2032 | Apr 2032 |
| US 9,556,274 | Lapsed on the fee record Jan 2021 | Jan 2021 |
| US 9,527,914 | this patent Dec 2020 | Dec 2020 |
| US 9,938,346 | In force Apr 2032 | Apr 2032 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 28, 2015 Reel 37394, frame 285 | Merrimack Pharmaceuticals, Inc. | U.S. Bank National Association, as Collateral Agent | Security Interest |
| Aug 24, 2016 Reel 39519, frame 52 | Baum, Jason; Johnson, Bryan; Lugovskoy, Alexey Alexandrovich; Xu, Lihui; Kohli, Neeraj; Fitzgerald, Jonathan Basil; Adams, Sharlene | Merrimack Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Apr 14, 2017 Reel 42254, frame 349 | U.S. Bank National Association | Merrimack Pharmaceuticals, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
A terminal disclaimer resolved from the filed document, referencing US 8,476,409, US 9,556,274, ends no earlier than this term, so it caps nothing.